B. Öberg

Trisodium Phosphonoformate, a New Antiviral Compound

Erik Helgstrand, B. Eriksson, N. G. Johansson et al. · Science · 1978 · 216 citations

Trisodium Phosphonoformate, Neurovirology, Medicine +9

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Klaus Überla, Christiane Stahl‐Hennig, D Böttiger et al. · Proceedings of the National Academy of Sciences · 1995 · 130 citations · Full text

Immunology, Antiviral Drug, Immunotherapy +18

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase

Lotta Vrang, B. Öberg · Antimicrobial Agents and Chemotherapy · 1986 · 83 citations · Full text

Medicinal Chemistry, Structural Requirements, Medicine +14

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.

Jan Balzarini, Anna Karlsson, Anne–Mieke Vandamme et al. · Proceedings of the National Academy of Sciences · 1993 · 79 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +19

Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

Anna‐Karin Larsson, K Stenberg, A.‐C. Ericson et al. · Antimicrobial Agents and Chemotherapy · 1986 · 78 citations · Full text

Molecular Virology, Guanosine Analogs, Medicine +9